Post by Protara Therapeutics

We’re excited to share that our THRIVE-3 clinical study website is live! THRIVE-3 is Protara’s registrational Phase 2b/3 study evaluating intravenous (IV) #CholineChloride in patients receiving long-term parenteral nutrition (PN). The site shares detailed information on IV Choline Chloride, patient resources, the study’s design, and how you or your child can participate in THRIVE-3. Learn more at www.thrive3study.com. #RareDisease #Choline #ClinicalNutrition, #ParenteralSupport #CholineDeficiency #ClinicalTrials